Carna Biosciences, Inc. (TYO:4572)
Japan · Delayed Price · Currency is JPY 214.00
+1.00 (0.47%)
Oct 24, 2025, 3:30 PM JST
Carna Biosciences Market Cap
Carna Biosciences has a market cap or net worth of 4.09 billion as of October 24, 2025. Its market cap has decreased by -39.59% in one year.
Market Cap
4.09B
Enterprise Value
3.05B
Revenue
572.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
214.00
Market Cap Chart
Since March 25, 2008, Carna Biosciences's market cap has decreased from 4.63B to 4.09B, a decrease of -11.64%. That is a compound annual growth rate of -0.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 4.09B | -28.64% |
| Dec 30, 2024 | 5.73B | -35.99% |
| Dec 29, 2023 | 8.95B | 21.11% |
| Dec 30, 2022 | 7.39B | -49.61% |
| Dec 30, 2021 | 14.67B | -2.43% |
| Dec 30, 2020 | 15.03B | -38.91% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 11.41T |
| HOYA Corporation | 7.83T |
| Daiichi Sankyo Company | 7.41T |
| Takeda Pharmaceutical Company | 6.71T |
| Otsuka Holdings | 4.38T |
| Terumo | 3.73T |
| Astellas Pharma | 2.91T |
| Olympus | 2.14T |